News & Updates

Better maternal cardiovascular health during pregnancy is associated with a lower risk of developmental delay in offspring, whereas poor maternal cardiovascular health during pregnancy contributes to a risk increase, according to a study.

Hepatic steatosis may raise the risk of major adverse cardiovascular events through increased non-calcified plaque burden, according to a study.

Among individuals undergoing common cardiovascular procedures, those with a preoperative diagnosis of dysphagia face an increased risk of postoperative mortality and complications, according to a retrospective study.

In patients with chronic obstructive pulmonary disease (COPD), acute exacerbations contribute to an increased risk of cardiopulmonary complications, as shown in a retrospective cohort study.

Cardiac rehabilitation produces functional capacity gains and quality of life improvements in patients with coronary heart disease (CHD), and a history of COVID-19 does not blunt this effect, according to a study.

In the treatment of hypercholesterolemia, the investigational oral small-molecule PCSK9 inhibitor laroprovstat appears well tolerated and may help reduce low-density lipoprotein cholesterol (LDL-C) levels when used in combination with rosuvastatin, according to a phase I study.

The oral dihydropyridine calcium channel blocker (CCB) amlodipine appears more beneficial than the beta-blocker metoprolol for managing hypertension in patients with heart failure with preserved ejection fraction (HFpEF), with greater effects on blood pressure (BP) control and exercise capacity, as shown in a randomized crossover trial.

Among patients with cardiovascular disease (CVD), the use of smartphones and wearable devices leads to substantial gains in daily steps and minutes spent in moderate-to-vigorous physical activity, according to a systematic review and meta-analysis.

In the treatment of patients with obstructive hypertrophic cardiomyopathy (HCM), aficamten exerts superior effects on a broad array of exercise measures compared with metoprolol, according to a secondary analysis of the phase III MAPLE-HCM trial.

Gout may increase susceptibility of atrial fibrillation (AF) patients to ischaemic stroke, according to new research.